Skip to main content
Earnings Labs
Innate Pharma S.A. logo

Innate Pharma S.A. (IPHA) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$1.50

+2.74%

Mkt Cap $150.90M

EPS — Estimate vs Actual

Quarterly History

Quarters are fiscal periods. Fiscal year ends in September.

Q4 2025

Sep 17, 2026

$6.44M$6.53M+1.48%-$0.33-$0.24+27.39%
Q4 2025

May 13, 2026

$2.67M$4.78M+79.14%-$0.35-$0.35+0.83%
Q3 2025

Sep 17, 2025

$1.96M$5.72M+191.96%-$0.14-$0.29-106.48%
Q2 2025

May 12, 2025

$18.24M$285.80K-98.43%-$0.27-$0.32-18.31%
Q4 2020

Nov 17, 2020

$39.74M$41.35M+4.03%-$0.34-$0.15+56.14%
Q2 2020

May 12, 2020

$19.07M$19.73M+3.45%-$0.43-$0.59-36.63%
Q4 2019

Nov 13, 2019

—$58.58M——$0.23—
Q2 2019

May 15, 2019

—$84.79M——$0.36—
Q2 2018

Jun 30, 2018

—$26.69M——-$0.30—
Q4 2017

Dec 31, 2017

—$26.70M——-$0.54—
Q2 2017

Jun 30, 2017

—$24.24M——-$0.49—
Q4 2016

Dec 31, 2016

—$47.24M——$0.30—
Q2 2016

Jun 30, 2016

—$22.99M——-$0.07—
Q4 2015

Dec 31, 2015

—$22.37M——$0.03—
Q2 2015

Jun 30, 2015

—$5.14M——-$0.17—
Q4 2014

Dec 31, 2014

—$4.53M——-$0.26—
Q2 2014

Jun 30, 2014

—$5.64M——-$0.26—
Q4 2013

Dec 31, 2013

—$12.85M——-$0.02—
Q2 2013

Jun 30, 2013

—$9.10M——-$0.08—
Q4 2012

Dec 31, 2012

—$8.47M——-$0.04—
Q2 2012

Jun 30, 2012

—$4.77M——-$0.07—
Q4 2011

Dec 31, 2011

—$7.65M——-$0.12—
Q2 2011

Jun 30, 2011

—$8.50M——-$0.13—
Q4 2010

Dec 31, 2010

—$2.87M——-$0.24—
Q2 2010

Jun 30, 2010

—$2.69M——-$0.23—
Q4 2009

Dec 31, 2009

—$5.53M——-$0.40—
Q2 2009

Jun 30, 2009

—$5.41M——-$0.39—
Q4 2008

Dec 31, 2008

—$9.34M——-$0.28—
Q2 2008

Jun 30, 2008

—$10.18M——-$0.30—
Q4 2007

Dec 31, 2007

—$9.51M——-$0.24—
Q2 2007

Jun 30, 2007

—$9.65M——-$0.24—
Q4 2006

Dec 31, 2006

—$4.07M——-$0.22—
Q2 2006

Jun 30, 2006

—$3.93M——-$0.22—
Q4 2005

Dec 31, 2005

—$769.35K——-$0.24—
Q2 2005

Jun 30, 2005

—$780.12K——-$0.25—